F. Vaylet

2.1k total citations
96 papers, 848 citations indexed

About

F. Vaylet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, F. Vaylet has authored 96 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in F. Vaylet's work include Lung Cancer Diagnosis and Treatment (33 papers), Lung Cancer Treatments and Mutations (28 papers) and Medical Imaging Techniques and Applications (14 papers). F. Vaylet is often cited by papers focused on Lung Cancer Diagnosis and Treatment (33 papers), Lung Cancer Treatments and Mutations (28 papers) and Medical Imaging Techniques and Applications (14 papers). F. Vaylet collaborates with scholars based in France, Senegal and Australia. F. Vaylet's co-authors include D. Debieuvre, B Lebeau, Gérard Zalcman, B. Milleron, Élisabeth Quoix, Fabrice Barlési, Virginie Westeel, Jean Trédaniel, I. Monnet and Jean-Luc Breton and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and CHEST Journal.

In The Last Decade

F. Vaylet

82 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Vaylet France 12 618 466 133 85 81 96 848
Shinjiro Sakamoto Japan 16 428 0.7× 331 0.7× 135 1.0× 43 0.5× 66 0.8× 98 838
Kyoko Otsuka Japan 15 613 1.0× 358 0.8× 105 0.8× 101 1.2× 45 0.6× 27 749
Steven Gans Netherlands 12 638 1.0× 481 1.0× 190 1.4× 59 0.7× 31 0.4× 20 941
P C Hoffman United States 16 570 0.9× 552 1.2× 146 1.1× 61 0.7× 141 1.7× 46 975
Isabelle Monnet France 14 840 1.4× 666 1.4× 144 1.1× 105 1.2× 72 0.9× 36 1.1k
Reury-Perng Perng Taiwan 20 748 1.2× 598 1.3× 164 1.2× 86 1.0× 128 1.6× 51 1.1k
Carlo Gobitti Italy 16 507 0.8× 369 0.8× 70 0.5× 54 0.6× 266 3.3× 55 994
I. A. Small Brazil 17 626 1.0× 438 0.9× 115 0.9× 62 0.7× 167 2.1× 49 973
Anne‐Marie Maddox United States 10 399 0.6× 469 1.0× 191 1.4× 47 0.6× 50 0.6× 18 754
Jin-Hyuk Choi South Korea 13 752 1.2× 433 0.9× 196 1.5× 68 0.8× 362 4.5× 18 1.2k

Countries citing papers authored by F. Vaylet

Since Specialization
Citations

This map shows the geographic impact of F. Vaylet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Vaylet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Vaylet more than expected).

Fields of papers citing papers by F. Vaylet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Vaylet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Vaylet. The network helps show where F. Vaylet may publish in the future.

Co-authorship network of co-authors of F. Vaylet

This figure shows the co-authorship network connecting the top 25 collaborators of F. Vaylet. A scholar is included among the top collaborators of F. Vaylet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Vaylet. F. Vaylet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bylicki, Olivier, Céline Ferlay, C. Chouaïd, et al.. (2013). Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study. Journal of Thoracic Oncology. 8(7). 906–914. 5 indexed citations
3.
Laffaire, Julien, Paul Hofman, Michèle Beau‐Faller, et al.. (2012). A Comparative and Integrative Approach Identifies ATPase Family, AAA Domain Containing 2 as a Likely Driver of Cell Proliferation in Lung Adenocarcinoma. Clinical Cancer Research. 18(20). 5606–5616. 56 indexed citations
4.
5.
Margery, J., Pierre Ruffiè, F. Rivière, et al.. (2011). Second-line therapy in patients with malignant pleural mesothelioma. French retrospective study 2005-2006. European Respiratory Journal. 38(Suppl 55). 2951–2951. 2 indexed citations
6.
Hofman, Paul, Marius Ilié, Véronique Hofman, et al.. (2011). Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma. Annals of Oncology. 23(7). 1738–1743. 48 indexed citations
7.
Rivière, F., et al.. (2011). Hairy trachea!!. European Journal of Cardio-Thoracic Surgery. 40(2). 530–530. 1 indexed citations
8.
Margery, J., F. Rivière, David Planchard, et al.. (2010). Traitement de seconde ligne dans le mésothéliome pleural malin. Étude rétrospective française (2005–2006). Revue de Pneumologie Clinique. 66(4). 255–259. 6 indexed citations
9.
Rivière, F., H. Le Floch, J. Margery, et al.. (2010). Cancer bronchique bifocal : une même histologie ?. Revue de Pneumologie Clinique. 67(2). 113–117. 1 indexed citations
10.
Groheux, David, Elif Hindié, Jean Trédaniel, et al.. (2009). TEP-TDM pour l’exploration du nodule pulmonaire solitaire : acquis et perspectives. Revue des Maladies Respiratoires. 26(10). 1041–1055. 6 indexed citations
11.
Floch, H. Le, et al.. (2007). Une péricardite atypique. Revue des Maladies Respiratoires. 24(9). 1147–1150. 2 indexed citations
12.
Margery, J., et al.. (2004). Risque thromboembolique et voyage en avion. Revue de Pneumologie Clinique. 60(6). 327–331. 1 indexed citations
13.
Gervais, R., A Ducoloné, Jean-Luc Breton, et al.. (2004). Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Annals of Oncology. 16(1). 90–96. 104 indexed citations
14.
15.
Vaylet, F., et al.. (1998). [Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography].. PubMed. 54(4). 187–95. 9 indexed citations
16.
Vaylet, F., et al.. (1998). Dans les suites d'une plongée.... Pneumatocèle baro-traumatique.. Revue de Pneumologie Clinique. 54(4).
17.
Urban, T., C Chastang, F. Vaylet, et al.. (1998). Prognostic Significance of Supraclavicular Lymph Nodes in Small Cell Lung Cancer. CHEST Journal. 114(6). 1538–1541. 13 indexed citations
18.
Natali, F, et al.. (1997). Communication brèveTrachéobronchopathie ostéochondroplastique: cinq observationsTracheobronchopathia osteochondroplastica: report of five cases. La Revue de Médecine Interne. 18(11). 3 indexed citations
19.
Lebeau, B, C Chastang, Luc Thiberville, et al.. (1995). Chimiothérapie des cancers bronchiques à petites cellules. Importance pronostique d'une réponse complète (1,280 patients). Groupe Petites Cellules.. La Presse Médicale. 24(4). 2 indexed citations
20.
Sadoun, D, et al.. (1992). Bronchogenic Carcinoma in Patients with Pulmonary Histiocytosis X. CHEST Journal. 101(6). 1610–1613. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinjiro Sakamoto Breakdown of academic impact, for papers by Kyoko Otsuka Breakdown of academic impact, for papers by Steven Gans Breakdown of academic impact, for papers by P C Hoffman Breakdown of academic impact, for papers by Isabelle Monnet Breakdown of academic impact, for papers by Reury-Perng Perng Breakdown of academic impact, for papers by Carlo Gobitti Breakdown of academic impact, for papers by I. A. Small Breakdown of academic impact, for papers by Anne‐Marie Maddox Breakdown of academic impact, for papers by Jin-Hyuk Choi
Rankless by CCL
2026